Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion

Neuroscience Letters

Volumn 451, Issue 1, 2009, Pages 34-39

  Scorisa, Juliana Milani ^a   Zanon, Renata Graciele ^a   Freria, Camila Marques ^a   de Oliveira, Alexandre Leite Rodrigues ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Glatiramer acetate; Immunomodulator; Motoneuron; Spinal cord; Synapse elimination; Ventral root avulsion

Indexed keywords

DNA BINDING PROTEIN; GLATIRAMER; GLIAL FIBRILLARY ACIDIC PROTEIN; PLACEBO; PROTEIN IBA 1; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GLIA CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL PLASTICITY; NERVE ROOT INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD MOTONEURON; VENTRAL ROOT;

ANIMALS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CELL SURVIVAL; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MOTOR NEURONS; NERVE DEGENERATION; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RATS, INBRED LEW; RHIZOTOMY; SPINAL CORD; SPINAL NERVE ROOTS; SYNAPTOPHYSIN;

EID: 58249134905     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.12.017     Document Type: Article

References (32)

1. Abercrombie M., and Johnson M.L. Quantitative histology of Wallerian degeneration: I. Nuclear population in rabbit sciatic nerve. J. Anat. 80 (1946) 37-50
2. Aharoni R., Arnon R., and Eilam R. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J. Neurosci. 25 (2005) 8217-8228
3. Aharoni R., Eilam R., Domev H., Labunskay G., Sela M., and Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19045-19050
4. Aharoni R., Kayhan B., Eilam R., Sela M., and Arnon R. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14157-14162
5. Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol. Ther. 98 (2003) 245-255
6. Emirandetti A., Graciele Zanon R., Sabha Jr. M., and de Oliveira A.L. Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy. Brain Res. 1095 (2006) 35-42
7. Filippi M., Rovaris M., Rocca M.A., Sormani M.P., Wolinsky J.S., Comi S., and European/Canadian Glatiramer Acetate Study Group. Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology 57 (2001) 731-733
8. Fridkis-Hareli M., Teitelbaum D., Gurevich E., Pecht I., Brautbar C., Kwon O.J., Brenner T., Arnon R., and Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells-specificity and promiscuity. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4872-4876
9. Gilgun-Sherki Y., Panet H., Holdengreber V., Mosberg-Galili R., and Offen D. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis. Neurosci. Res. 47 (2003) 201-207
10. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
11. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 (2000) 5283-5291
12. Holtz A., Nystrom B., Gerdin B., and Olsson Y. Neuropathological changes and neurological function after spinal cord compression in the rat. J. Neurotrauma 7 (1990) 155-167
13. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., and Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 290 (2000) 2155-2159
14. Khan O., Shen Y., Caon C., Bao F., Ching W., Reznar M., Buccheister A., Hu J., Latif Z., Tselis A., and Lisak R. Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis. Mult. Scler. 11 (2005) 646-651
15. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., and Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7446-7451
16. Kirwin S.J., Dowdell K.C., Hindinger C., Feng N., Bergmann C.C., Hinton D.R., and Stohlman S.A. Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis. J. Neuroimmunol. 178 (2006) 30-39
17. Kishino A., Ishige Y., Tatsuno T., Nakayama C., and Noguchi H. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp. Neurol. 144 (1997) 273-286
18. Koliatsos V.E., Price W.L., Pardo C.A., and Price D.L. Ventral root avulsion: an experimental model of death of adult motor neurons. J. Comp. Neurol. 342 (1994) 35-44
19. Li Q.Q., and Bever C.T. Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells. Brain Res. Mol. Brain Res. 87 (2001) 48-60
20. Maier M., Kuhnert A.V., Taheri N., Sattler M.B., Storch M.K., Williams S.K., Bahr M., and Diem R. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am. J. Pathol. 169 (2006) 1353-1364
21. Marques K.B., Santos L.M., and Oliveira A.L. Spinal motoneuron synaptic plasticity during the course of an animal model of multiple sclerosis. Eur. J. Neurosci. 24 (2006) 3053-3062
22. Novikov L., Novikova L., and Kellerth J.O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience 79 (1997) 765-774
23. Novikova L., Novikov L., and Kellerth J.O. Effects of neurotransplants and BDNF on the survival and regeneration of injured adult spinal motoneurons. Eur. J. Neurosci. 9 (1997) 2774-2777
24. Oliveira A.L., Thams S., Lidman O., Piehl F., Hokfelt T., Karre K., Linda H., and Cullheim S. A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17843-17848
25. Piehl F., Hammarberg H., Tabar G., Hokfelt T., and Cullheim S. Changes in the mRNA expression pattern, with special reference to calcitonin gene-related peptide, after axonal injuries in rat motoneurons depends on age and type of injury. Exp. Brain Res. 119 (1998) 191-204
26. Racke M.K., Martin R., McFarland H., and Fritz R.B. Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation. J. Neuroimmunol. 37 (1992) 75-84
27. Sanna A., Fois M.L., Arru G., Huang Y.M., Link H., Pugliatti M., Rosati G., and Sotgiu S. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 143 (2006) 357-362
28. Tator C.H., and Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86 (1997) 483-492
29. Teitelbaum D., Sela M., and Arnon R. Copolymer 1 from the laboratory to FDA. Isr. J. Med. Sci. 33 (1997) 280-284
30. Thams S., Oliveira A., and Cullheim S. MHC class I expression and synaptic plasticity after nerve lesion. Brain Res. Rev. 57 (2008) 265-269
31. Zanon R.G., and Oliveira A.L. MHC I upregulation influences astroglial reaction and synaptic plasticity in the spinal cord after sciatic nerve transection. Exp. Neurol. 200 (2006) 521-531
32. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., and Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 125 (2002) 2381-2391